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The human body (primarily the intestinal tract, the oral cavity, and the skin) harbours approximately 1,000 diﬀerent bacterial
species. However, the number of archaeal species known to colonize man seems to be conﬁned to a handful of organisms within
the class Euryarchaeota (including Methanobrevibacter smithii, M. oralis,a n dMethanosphaera stadtmanae). In contrast to this
conspicuously low diversity of Archaea in humans their unique physiology in conjunction with the growing number of reports
regarding their occurrence at sites of infection has made this issue an emerging ﬁeld of study. While previous review articles
in recent years have addressed the putative role of particularly methanogenic archaea for human health and disease, this paper
compiles novel experimental data that have been reported since then. The aim of this paper is to inspire the scientiﬁc community
of “Archaea experts” for those unique archaeal organisms that have successfully participated in the human-microbe coevolution.
1.Introduction
A striking feature of the human microbiota is the conspic-
uous imbalance of species diversity between bacteria and
archaea. So far, over thousand distinct bacterial species or
phylotypes have been recovered from the human intestinal
tract, and more than 700 bacterial phylotypes have been
identiﬁed in the human oral cavity (e.g., [1, 2]). Although
most intestinal microbes initially enter through the oral
cavity, both compartments share surprisingly few bacterial
species [3, 4]. The underlying mechanisms that lead to the
spatial separation of bacterial communities seem to apply
also to human archaea; however, the striking diﬀerence is
the extremely reduced diversity compared to bacteria. Only
three distinct species within the group of Euryarchaeota
have been regularly detected within the human body.
Among these is the primary colonizer of the human gut
system Methanobrevibacter smithii and the less frequently
found species Methanosphaera stadtmanae, while in the oral
cavity M. oralis is the predominating methanogenic species.
Despite this low diversity and the generally lower abundance
compared to human bacteria the unique physiology and
energy metabolism of methanogens suggest that they may
play a previously underestimated role for human health
and disease. Previous reviews have already discussed the
theoretical possibility that archaea might act as human
pathogens (e.g., [5–7]). The current paper while not recapit-
ulating these reviews compiles knowledge from most recent
ﬁndings (arising from more than 20 additional studies,
primarily from the last three years) that have substantially
complemented our view of diversity and prevalence of
euryarchaeota in humans as well as their association with
health and disease.
2.How CanArchaeaAffect HumanHealth?
Before discussing novel ﬁndings, it should be pointed out
that there are two basic mechanisms under discussion by
which methanogens theoretically could inﬂuence our health.
Firstisthroughinterspecieshydrogentransfer[6],amutually
beneﬁcial, unidirectional process that plays a central role2 Archaea
in the anaerobic fermentation of organic matter in natural
environments.Bywaysofsyntrophicinteractions,thismeans
that methanogens in humans might support the growth
of fermenting bacteria, which themselves could be either
true pathogens or at least opportunistic pathogens but also
members of the physiological ﬂora (so-called commensals),
which inﬂuence our health in other indirect ways. The
support of human pathogens is feasible at sites of infections,
like periodontal pockets or infected tooth-root canals, where
methanogens have been frequently identiﬁed. The support
of a physiological ﬂora is feasible in the human intestinal
tract system. Here, even in the absence of an acute infection,
the type of interactions, substrates, and end-products (i.e.,
the type of syntrophic partners) may nonetheless be decisive
for the status of health (e.g., colon cancer or obesity, see
later in this paper). Of course methanogens are not the only
hydrogenotrophic groups as sulfate-reducers and acetogenic
bacteria both of which are present in the human body
potentially are also capable of analogous interactions (e.g.,
reviewed in [8]). Even if these three functional microbial
guilds are alternatively involved in interspecies hydrogen
transfer depending on environmental conditions and the
individual ecological niche, they can—as a whole—be con-
sidered as keystone organisms that coregulate the activity
of the remaining fermenting microbiota and as such are
responsible for the overall microbial homeostasis.
Thesecondmechanismunderdiscussionisthecapability
of methanogens to eﬀectively transform heavy metals or
metalloids into volatile methylated derivatives which are
known to be more toxic than the original compounds
[9]. Again, also this feature is shared with some bacteria,
but interestingly, methanogens, isolated from the human
gut, have been shown to possess a much higher potential
for metal(loid) derivatization (e.g., bismuth, selenium, tel-
lurium, and mercury) in vitro compared to bacterial gut
isolates [10]. The immediate consequences of such transfor-
mation for human health have to be elucidated. However,
as an example use of bismuth containing compounds in
pharmaceutical products has been linked with poisoning
during prolonged medical therapy with the consequences of
renal failures and mental disorders as described by Michalke
et al. [9]. It is likely that frequent exposure with such heavy
metals through use of cosmetics or pharmaceutical products
increases the possibility of its methylation by methanogens
followed by increased toxicity. Whether or not methanogens
in the oral cavity also have the potential or opportunity
for such toxic transformations has not been investigated so
far, but given the high number of foreign material used
in dentistry this could be of great clinical importance as
well.
While the ﬁrst mechanism mentioned above would
constitute an indirect form of pathogenesis, the second
mechanism would actually be a direct virulence factor. In
any case, if one or both of those mechanisms have an aﬀect
on our health this would constitute a novel paradigm of
microbial pathogenesis and could open new horizons for
future research including the challenge of developing novel
concepts for therapy of infectious diseases and/or human
physiological disorders.
3. Methanogens inthe Oral Cavity:
What Is New?
Methanobrevibacter oralis, the major archaeal player in
the oral cavity, has long been identiﬁed in periodontal
pockets. Its proportional increase with severity of disease
has meanwhile been conﬁrmed by various groups. Whether
or not interspecies hydrogen transfer is a driving force of
this polymicrobial disease remains still unknown. However,
our recent cross-sectional analysis of periodontal samples
from more than one hundred patients based on selected
marker genes (i.e., mcrA, dsrAB,a n dfhs)n o to n l yr e v e a l e d
the consistent presence of the three major hydrogenotrophic
microbial groups (i.e., methanogens, dissimilatory sulfate
reducers, and reductive acetogens) but also demonstrated
negative interactions among these as well as an increase
of their relative proportions with severity of the disease
[11]. Given the varying microbial interactions and the
overall heterogeneity of the plaque bioﬁlm composition,
both temporarily and among individuals, the observed
pattern suggested that antagonistic interactions among H2-
utilizersseemtoprevail,withthedominanceofmethanogens
and sulfate-reducers over acetogens being associated with a
clinically more harmful situation for the host.
Human archaea have become into another potentially
compromising position as M. oralis was identiﬁed in a
speciﬁc form of oral infections, namely, apical periodontitis,
by our group recently [12]. Apical periodontitis is the result
of the infection of a tooth’s root canal, and it has long
been known that this location—devoid of microbes in a
healthy state—can only be invaded steadily by few distinct
members of the oral microﬂora. Apparently these organisms,
which are generally referred to as endodontic pathogens,
havethepropertiesnecessarytoinvadetubulesandtosurvive
within the intratubular environment. Yet, quite naturally,
one hesitates to apply this term also to M. oralis simply
based on its presence in infected root canals. However,
this aspect certainly warrants further investigation. Recent
studies on US patients and Japanese patients have conﬁrmed
the presence of M. oralis in infected root canals [13,
14]. The latter study provided three additional important
aspects worth notifying. First, the combined presence of
archaea (i.e., M. oralis) and bacteria was associated with a
signiﬁcantly higher prevalence of clinical symptoms (e.g.,
pain) compared to the number of cases with sole presence
of bacteria. Second, archaea were identiﬁed also in persisting
or secondary endodontic infections, that is, in cases of failed
root canal treatment, usuallythe result of microbes surviving
the disinfection procedures. This is interesting, since we
do not know how archaea respond to classical endodontic
disinfectants such as sodium hypochloride or chlorhexidine.
Lastly, Jiang et al. [14] identiﬁed archaea using an rRNA-
based approach. This demonstrates that M. oralis was in
fact present in a viable state in infected root canals and
reducesspeculationsthattheformerDNA-basedstudiesonly
detected the—in comparison to RNA—much more stable
DNA released from dead or damaged archaeal cells.
First data about the immunogenicity of M. oralis after
oral infections has also been obtained most recently. YamabeArchaea 3
et al. [15] investigated the distribution of M. oralis in
Japanese patients with periodontitis and examined the
serum IgG responses to archaeal components. Western
immunoblotting detected IgG antibodies against M. oralis
in sera from 8 of 11 tested patients suggesting the potential
of M. oralis as an antigenic component of periodontitis.
Furthermore, in a follow-up study Yamabe et al. [16]
identiﬁed one of the antigenic molecules as subunits of
the type II chaperones (Cpn II = heat shock proteins that
occur in Archaea and Eukarya). The authors [16] also
demonstrated cross-reactivity with the human chaperonin
CCT applying western immunoblotting. This is especially
important given our knowledge regarding cross-reactivity of
bacterial heat shock proteins with human molecules. For
instance the bacterial Hsp60 (group I Cpn) are known to
be highly antigenic molecules [17, 18] present in many
pathogenic bacteria, and several immune disorders, such as
rheumatoid arthritis or rheumatoid fever, are thought to be
triggered by these molecules. Although further investigation
is needed for deﬁnite conclusions, the data indicate that
antigenic molecules of M. oralis have the potential to act as
modiﬁer or even initiator of inﬂammation in periodontal
lesions.
4. Methanogens in the HumanGut System:
What Is New?
As we know by the results of virtually all studies M.
smithii is the major archaeal component in the human gut
system, while Methanosphaera stadtmanae is a less frequently
detected species. The importance of M. smithii in this
complex microbial ecosystem, primarily its role as H2-
consumer and supporter of the fermenting microbiota, has
been previously addressed [6, 7]. H2-consumption and data
regarding interactions among the three hydrogenotrophic
microbial groups in the gut and their possible relation to
disease have been discussed more comprehensively recently.
The disorders in which methanogens are probably involved
are inﬂammatory bowel disease (or Crohn’s disease), irri-
table bowel syndrome, colorectal cancer, diverticulosis, and
obesity. For detailed information the reader is referred to the
articles by Nakamura et al. [8] and Roccarina et al. [19]. In
the essence, a direct or indirect contribution of methanogens
to the development of gastrointestinal disorders is unclear
and remains an ongoing subject of debate. Currently it is
impossible to draw deﬁnite conclusions because of fragmen-
tized and even controversial ﬁndings. In particular, little is
known regarding the extent to which the hydrogenotrophic
microbiota varies in composition or metabolic speciﬁcity
among individuals and how the interactions with the
remaining microﬂora aﬀect our health. By way of example,
let us consider the ﬁndings by Abell et al. [20]. The authors
found a negative correlation between mean fecal butyrate
concentration and methanogen abundance by testing 8
individuals weekly over a 12-week period by using molecular
methods. Their data suggest an indirect association of
methanogens with colorectal cancer or other gastrointestinal
disorders,consideringtherecognizedimportanceofbutyrate
as a primary energy source for cells lining the colon and for
protecting against activities associated with carcinogenesis
(e.g., enhancement of cell cycle arrest and apoptosis, [21,
22]). However, it is unclear what the underlying mechanisms
arethatlinkhighnumbersofmethanogenswithlowbutyrate
concentrations and what are the cause and eﬀect. One expla-
nation could be that methanogens live in syntrophy with
butyrate degrading organisms via interspecies H2-transfer.
While such interactions exist in other environments, to
our knowledge respective syntrophic bacterial partners (i.e.,
members of the family Syntrophomonadacaea) are not in the
molecular inventories of the microbial gut environments [1].
Abell et al. [20] speculated instead that in the presence of
high numbers of methanogens butyrate could not be formed
by known gut bacteria using acetate, such as Faecalibac-
terium prausnitzii and Roseburia intestinalis, because acetate-
producing organisms (acetogens) had been outcompeted by
the methanogens. This scenario would imply that increased
methanogenic activity in the gut leads to reduced availability
or concentrations of acetate. But this in turn conﬂicts with
the results of Samuel and Gordon [23], which suggest
that syntrophic archaeal-bacterial interactions in the gut
lead to increased acetate levels. From these examples it
becomes clear that more studies are needed for drawing
deﬁnite conclusions and that the identity of syntrophic
partners is crucial here, as they modulate the type and
concentration of short-chain fatty acids in the gut system.
The latter study is also interesting with respect to the human
physiological disorder obesity. Based on a gnotobiotic mouse
model a link between M. smithii and host energy balance
could be established [23]. The colon of germ-free mice
was colonized with a polysaccharide-degrading bacterium
(Bacteroides thetaiotaomicron), a sulfate-reducing bacterium
(Desulfovibrio piger), and M. smithii in diﬀerent combi-
nations [23]. B. thetaiotaomicron degraded polyfructose-
containing glycans more eﬃciently in the presence of M.
smithii. In addition, mice colonized with these two microbes
showed increased fermentation products and an increase in
adiposity (increased storage of energy in fat cells). These
eﬀectswerenotobservedaftercocolonizationwiththepairB.
thetaiotaomicron and D. piger (as alternative H2-consumer),
emphasizing the critical role of M. smithii in promoting
polysaccharide degradation, followed by absorption of the
fatty acids that lead to liver lipogenesis and formation of
fat deposits. These experiments substantiate the hypothesis,
that, by providing the ﬁnal step in energy extraction from
degradation of organic compounds, methanogens could
alter the whole gut physiology with profound consequences
for the host. As such they could also be an interesting
target for therapeutical manipulation of obesity. In fact,
further evidence has recently been provided by Zhang et
al. [24]. Using real-time PCR, they detected signiﬁcantly
higher numbers of H2-utilizing methanogenic Archaea in
three obese individuals than in three normal-weight or three
post-gastric-bypass individuals. The numbers of the H2-
producing Prevotellaceae were also highly enriched in the
obese individuals supporting the hypothesis that interspecies
H2-transfer between bacterial and archaeal species is an
important mechanism for increasing energy uptake by the4 Archaea
humanlargeintestineinobesepersons.Thespeculatedinter-
actions between methanogens and Prevotellaceae however
need further veriﬁcation because of the low number of
individuals tested.
The above examples [23, 24] were chosen here,
because somewhat conﬂicting results have been obtained by
Armougom et al. [25] who found the number of M. smithii
in 20 obese persons compared to 20 normal weight persons
not signiﬁcantly increased. Instead they found a signiﬁcantly
increased number of M. smithii in nine anorexia nervosa
patients compared to the normal weight persons. This result,
also produced by real-time quantitative PCR, shows that
more research is needed to truly understand the ecology of
the human gut ﬂora and the role of archaea for intestinal
disorders.
5. An Update on Euryarchaeota
DiversityinHumans
M. smithii, M. oralis as well as Methanosphaera stadtmanae,
are the only archaeal species that have been successfully
cultivated and isolated from human habitats (i.e., the
intestinal tract, vagina, and oral cavity) in the past. Applying
PCR-based technologies targeting the 16S rRNA gene and/or
the mcrA gene directly to clinical specimens has conﬁrmed
the presence of these species in relevant numbers in several
studies. Nonetheless recent ﬁndings have shown that the
diversity of Archaea in humans is higher and that additional
taxa, that have been recovered by molecular methods, all
belong to the group of Euryarchaeota.
As a close relative to M. smithii and M. oralis,w e
have previously veriﬁed the existence of a third phylotype
(“phylotype 3”) in periodontal pockets and within infected
dental root canals [26]. First 16S rRNA gene sequences of
this putative organism had already been reported earlier
(e.g., [27]), however only our combined recovery of both
16S rRNA and mcrA gene sequences with ﬁtting topology
of inferred phylogenetic trees from the same individual
gave suﬃcient conﬁdence that humans are colonized by a
third Methanobrevibacter phylotype. This ﬁnding may sound
trivial given the high archaeal diversity in environmental
habitats,butnotgiventheextremereducedarchaealdiversity
in humans. Interesting questions that arise are, whether this
uncultured organism shares individual niches or competes
with M. oralis and why it has escaped cultivation so far.
Though it is likely that this organism is cultivable with the
same conditions as M. smithii and M. oralis, failure so far
is probably due to its lower prevalence in human clinical
samples [26].
Irrespective of this, the diversity of human-associated
Euryarchaeota in the gut system seems to be larger than
previously thought according to two independent studies.
Scanlan et al. [28] and Mihajlovski et al. [29] reported the
identiﬁcation of mcrA gene sequences only distantly related
to cultured methanogens from the ﬁve recognized orders
(i.e., Methanomicrobiales, Methanopyrales, Methanobacteri-
ales, Methanococcales,a n dMethanosarcinales). It has been
hypothesized that this novel mcrA gene type corresponds
to an uncultured phylotype that makes up a putative sixth
methanogenic order [29]. In a subsequent extended study,
Mihajlovski et al. [30] identiﬁed four additional mcrA gene
types also grouping within the same clade of this putative
sixth methanogenic order. In addition, these sequence types
shared close to moderate similarity with a number of clone
sequences recovered from animal studies such as pig feces
andfromcattlerumens[30],furthersupportingthepossibil-
ity of a novel group of Euryarchaeota adapted to the animal
intestinal tract. By comparing fecal samples from human
volunteers of diﬀerent ages Mihajlovski et al. [30] also found
that these novel sequence types were signiﬁcantly more
prevalent in elderly people than in young people. Interest-
ingly the same samples containing the novel mcrA sequence
types also revealed 16S rRNA gene sequences grouping
within the Thermoplasmatales b u tw i t hn oc u l t u r e dr e l a t i v e s .
If corresponding to each other, the conclusion would be
that a novel sister group of Thermoplasmatales probably
capable of methanogenesis exists in the human gut system.
Otherwise, one could conclude that the mcrA-genotypes
may represent organisms that share the gut environment
with other archaeal species related to Thermoplasmatales.
Thermoplasma-like sequences have also been identiﬁed in
the periodontal pockets [31], however, with a sequence
identity to those sequences found in the human gut of only
93%,probablyreﬂectingspeciﬁcadaptationtothisparticular
human ecosystem. In any case these ﬁndings emphasize the
increased diversity of Euryarchaeota in humans, in both the
intestinal tract and the oral cavity.
Further novel insights regarding archaeal diversity in
humans were previously reported by Oxley et al. [32]. In an
analysis of the microbiota in colonic mucosal biopsies from
8 out of 39 patients with inﬂammatory bowel disease they
found 16S rDNA sequences representing a phylogenetically
rich diversity of halophilic archaea (15 diﬀerent phylotypes)
from the Halobacteriaceae (haloarchaea), including those
with no directly related cultured representatives. Further-
more, aerobic enrichment cultures prepared from a patient
biopsy at low salinity (2.5% NaCl) yielded haloarchaea
sequence types. Microscopic observation after ﬂuorescence
in situ hybridization provided evidence of the presence
of viable archaeal cells in these cultures. These results
prove the survival of haloarchaea in the human digestive
system and suggest that they may be members of the
mucosal microbiota. Whether they constitute regular colo-
nizers and whether they occur in abundance comparative
to methanogenic archaea are unknown so far. The study
of Oxley et al. [32] is the ﬁrst that clearly shows that the
diversity of viable Euryarchaeota in humans goes beyond
methanogenic archaea. What the relationship of the occur-
rence of halophilic archaea is with respect to inﬂammatory
bowel disease remains speculative for now. One possibility is
that they stem from precolonoscopy saline lavage solutions.
However, Oxley et al. [32] consider this possibility as
unlikely, since they detected diﬀerent halophilic phylotypes
in saline lavage solutions not directly related to those found
in the biopsies. This aspect by its own is puzzling, as it
indicates that the manufacturer providing precolonoscopy
saline lavage solutions used salt from natural sources directlyArchaea 5
without sterilisation. Alternatively the solution itself may
contain only the DNA of killed cells, left after heat-
sterilisation and/or ﬁltration. In any case, Oxley et al. [32]
found also halophilic archaea in some patients that had not
received the saline lavage solution. In addition halophilic
archaeahavealsobeenreportedinfecalsamplesfromKorean
probands, who were not suﬀering from Crohn’s disease [33],
leaving the question for the origin of those extremophilic
archaea unanswered for now. Since the human colon is not
an obvious salty environment, the physiological basis of an
opportunistic colonization by haloarchaea as indicated by
the above studies is another intriguing question.
In summary, recent ﬁndings have enlarged the known
diversity of euryarchaeota in humans, now including further
phylotypes of Methanobrevibacter, but even an entire novel
order of methanogens, members of Thermoplasmatales, and
Halobacteriac. The question arises here, why their presence
has largely eluded detection in many studies before. One
apparent answer is that the primers, used to amplify their
DNA, were not speciﬁc and/or sensitive enough. From our
experiences, most primers designed in older studies for
characterization of environmental archaea are not suitable
for detection of human-associated archaea. In many cases
cross-reaction with human DNA was observed in our lab-
oratory, sometimes even leading to PCR bands with the size
indicating successful archaeal 16S rRNA gene ampliﬁcation.
Yet, even more frustrating were the results from subsequent
sequence analysis. Hence, careful design of novel primers
as well as the use of multiple molecular targets (16S rDNA
and mcrA) is highly important in recovering a wider range
of human methanogens. An alternative approach may be
the separation of human and microbial DNA prior to PCR
ampliﬁcation.Twodiﬀerentapproacheshavebeendeveloped
[34], which might also be useful for metagenomic studies
of the human microbiome [35]. The fact that the choice
of the molecular approach greatly inﬂuences our perception
of archaeal diversity and prevalence in humans can be best
illustrated in another most recent study. Dridi et al. [36]
developed a new protocol for the extraction and PCR-based
detection of M. smithii and M. stadtmanae DNA in human
stool samples. The protocol included a mechanical lysis
step with glass beads which was applied twice combined
with an overnight incubation with proteinase K. PCR-based
detection included newly designed primers targeting the 16S
rRNA gene but also the rpoB gene, which encodes the β
subunit of RNA polymerase, one of the core genes shared
by Bacteria and Archaea. By testing fecal samples from 700
volunteers by RTQ-PCR, they found M. smithii in virtual
all individuals and M. stadtmanae in almost 30% of cases.
Double treatment with glass beads was performed because
gut methanogens have been shown to possess a proteinase
K resistant cell wall [37]—and apparently the extensive
mechanical action was decisive in the eﬃciency of DNA
extraction. Similarly Salonen et al. [38] found an increased
prevalence of methanogenic Archaea in human fecal samples
by repeated mechanical disruption steps, compared to other
extraction protocols. These ﬁndings revise our perspective
that methanogens colonize the gut of only about half of
the human population. Instead, M. smithii appears as an
almost ubiquitous inhabitant of the intestinal microbiome.
As such it sheds additional light on the paramount role
that methanogenic species may have in the overall microbial
ecology of the digestion process. For deeper understanding it
is therefore even more important to monitor changes in the
archaeal gut ﬂora under diﬀerent physiological, pathological,
and therapeutical (e.g., administration of antibiotics) condi-
tions.
6. Open Questions
6.1. Have We Already Grasped the Entire Archaeal Diversity
in Humans, and Is This Diversity Really Conﬁned to the
Group Euryarchaeota? With the use of redeﬁned primer
systems and application of modern molecular techniques
such as deep sequence analysis via pyrosequencing and with
the expansion to other habitats (e.g., the human stomach,
the oesophagus), it is likely that some surprising ﬁndings
regarding archaeal prevalence and diversity will show up
in the near future. Whether or not archaea other than
euryarchaeota are colonizers of the human body is unknown
so far. However, members belonging to Crenarchaeota have
been detected in the human gut system previously with PCR-
based methods [39]. In order to reproduce this intriguing
result we tested the same primers and PCR conditions in
our laboratory. No 16S rRNA genes of crenarchaeota were
obtained in our study, neither from ﬁve selected fecal nor
from ﬁve oral samples, so that the ﬁndings of Rieu-Lesme
et al. [39] remain anecdotal for now. In addition, when
testing further Crenarchaeota speciﬁc-primers [40]w eo n l y
ampliﬁedanddetectedthe16SrRNAgeneofM.oralisinoral
samples, indicating an apparent lack of crenarchaeota and an
abundance of M. oralis suﬃciently high enough to overcome
mismatches to the crenarchaeota primers. In another ﬁrst
attempt we tested published primers speciﬁcally designed
for the detection of Korarchaeota [41]a n dNanoarchaeota
[42] with oral samples. In both cases we observed cross-
reaction with human DNA, even under highly stringent
PCR conditions. Again, new primer systems and/or eﬃcient
strategies for removal of human DNA are required to ﬁnd
clear answers.
6.2. What Prevents Most Archaea from Colonization of the
Human Body? Apparently, the human microbial ecosystem
follows the trend of many environmental habitats, in which
the observed diversity of bacteria is higher than that of
archaea [43]. The underlying mechanisms for this, though
unknown, may be partially similar. However, within humans
additional selective forces such as the immune system aﬀect
the microbial colonization pattern. And, once established,
the human physiological microﬂora seems to defend its
own acquired status very eﬀectively against “newcomers.”
This may even, at least partially, explain the diﬀerential
colonization pattern of the oral and gut environment [44].
One could also speculate that some archaea simply do
not have the opportunity to colonize the human body but
once they get access colonization is possible. The presence
of Halobacteriaceae in Morbus Crohn patients, probably6 Archaea
inserted through contaminated salt lavage solution, may
be an example for this [32]. Conversely, several viable
methanogenic taxa (others than those so far detected in
h u m a n s )c a nb ef o u n di nf o o d ,p r i m a r i l yi nv e g e t a b l e sb u t
also in nuts and meat [45]. In addition, nonmethanogenic
archaea, including crenarchaeota, have been found in fer-
mented seafood [46]. Hence, those organisms (with the
possible exception of halophilic archaea) get the opportu-
nity, however, seem incapable for steady colonization. One
possible explanation that most archaea cannot colonize the
human body could be the uniqueness of their biochemistry.
Archaea use a variety of “exotic” cofactors that bacteria or
eukaryotes neither synthesize nor require [47]. So, from
the standpoint of nourishment human ecological niches
could be an unpleasant environment for archaea, as they
are as “biochemical outsiders” in an inferior position when
competing with bacteria. Even more exciting then becomes
the question, which strategies M. smithii and M. oralisa n d
other human archaea have developed to overcome this key
disadvantage. Whole genome analysis of several M. smithii
strains in comparison with close relatives from environ-
mental systems has shown, that M. smithii is in fact highly
adapted to the gut system [48]. This includes its capability
of (i) production of surface glycans resembling those found
in the gut mucosa, (ii) expression of adhesion-like proteins,
(iii) consumption of a high variety of fermentation products
by saccharolytic bacteria, and (iv) eﬀective competition for
nitrogenous nutrient sources [48]. It will be highly interest-
ing to compare its genome with that of M. oralis, discovering
which genes are responsible for successfulcolonization of the
human oral cavity versus gastrointestinal tract.
6.3. Which Are the Syntrophic Partners of Methanogens in
Humans, and Are These Organisms Consistent or Vary over
Time and Space and among Individuals? Possible bacterial
candidates can be deduced from correlation analysis of
species prevalence and abundance using molecular methods.
For instance, some evidence exists for possible interactions
between H2-producing Prevotellacea and M. smithii in the
human gut system [24]o rSynergistes and M. oralis in
endodontic infections [26, 49]. A manuscript from our
laboratory is currently underway describing the correlations
between M. oralis and recognized periodontal pathogens.
Such correlations, however, not necessarily prove syntrophic
interactions but can also mean that other unknown factors
favour the simultaneous growth of both archaeal and
bacterial niche partners. More precisely, it can be concluded
that Bacteroides thetaiotaomicron and M. smithii can coop-
eratively degrade polysaccharides, as the gnotobiotic mice
studies of Samuel and Gordon [23] have shown. While it is
plausible to assume that this interaction truly occurs in the
human gut, there might exist a larger spectrum of syntrophic
partners. Stable isotope probing (SIP) of diﬀerent organic
compounds, such as butyrate or propionate has become
a popular method to investigate syntrophic methanogen-
bacterial interactions in various habitats (e.g., [50, 51]).
In order to understand the full range of possible syn-
trophic partners in humans, analogous experiments could
be designed based on the incubation of human fecal or oral
plaque samples with various short-chain fatty acids labelled
with 13C followed by subsequent analysis of marker genes
including those involved in methanogenesis (e.g., the mcrA).
Suchexperimentswouldnotonlyleadtotheidentiﬁcationof
interacting bacterial partners but also—once established—
enable to monitor the dynamics of such partnerships over
time through repeated sampling and testing. For example,
the feasibility of linking structure and function of human
microbes using SIP has recently been demonstrated in a
study analyzing denitriﬁcation in human dental plaque
samples [52].
6.4. How likely Is the Involvement of Archaea in Infectious
Processes of Otherwise Sterile Sites Such as Brain Abscesses,
Peritonitis, or Endocarditis? This is an intriguing question,
given that distinct members of the endogenous microﬂora
(from the oral cavity or gut system), while harmless in their
natural location, can cause severe life-threatening infections.
Syntrophicinteractionswithmethanogenscouldbeadriving
factor for such kind of polymicrobial diseases, provided
that methanogens also get access to primary sterile sites.
One already proven example is the infection of a dental
root canal leading to apical periodontitis [12–14]. However,
our initial attempts to look for methanogens in extraoral,
“real” clinical samples were unsuccessful so far, but most
likely due to the dominating amounts of human DNA cross-
reactingwiththeprimersystems.Thenewlydesignedprimer
s y s t e m sm e n t i o n e da b o v ea sw e l la sm o r ee ﬃcient DNA
extraction methods may help to give clarity here. However,
if methanogenic archaea or nonmethanogenic archaea play
a role in life-threatening infections, their sheer diagnosis on
the sole base of molecular studies would not be suﬃcient.
Given the great implication of such ﬁndings (e.g., resistance
to most antibiotics and need for entire new targets for
therapy or prevention), it would be of utmost importance
to obtain cultured isolates for further veriﬁcation and phe-
notype characterization including resistance/susceptibility
testing.
7. FinalRemarks
Archaeal colonization of human anatomical sites has long
been neglected as research objective. Conversely, there has
been quite some attention for archaea and their role in
animals, including but not limited to ruminants and insects
(reviewed in [53]). It is possible that archaeal interactions
with the animal host parallel the situation in humans. In
particular termites have been relatively well studied, and
interestinglythehindgutofso-calledlowertermitesharbours
mainly archaeal species closely related to Methanobrevibacter
[54].Termitesmight thereforefunctionasasuitableandeasy
to study model ecosystem for gaining more insights into the
biological basis of archaeal colonization in humans.
A major step toward a better understanding of the
function and dynamics of human archaea will be done by
results originating from the Human Microbiome Project
[35]. Given the recognized plasticity of the genomes ofArchaea 7
most opportunistic pathogenic bacteria (e.g., acquisition of
virulence factors or antibiotic resistance mechanisms), it is
important to assess the genomic architecture of M. smithii
and M. oralis in diﬀerent individuals as well. Metagenomic
analyses for establishing a microbial gene catalogue of the
human gut or oral cavity [55] will not only reveal whether
or not horizontal gene transfer is also common among
those archaea but also—once a suﬃciently high number
of individuals are tested—if certain human physiological
disorders are potentially linked with a given archaeal strain
(or phylotype). In addition, concerted activities of clinicians
and microbiologists from diﬀerent areas (i.e., medical and
archaea experts) will be needed in future to elucidate (and
possibly interfere with) the role of Euryarchaeota in human
health and disease.
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